American Society of Hematology/LinkedIn
Aug 30, 2026, 10:23
American Society of Hematology Updates ITP Treatment Guidelines for Adults
American Society of Hematology shared a post on LinkedIn:
“ASH has released 2026 clinical practice guidelines on initial and second-line therapy for adults with primary immune thrombocytopenia (ITP).
The guidelines include updated recommendations to support evidence-based treatment decisions and shared decision-making between clinicians and adults living with primary ITP.
Explore the guidelines and supporting resources.”
Other posts featuring American Society of Hematology on Hemostasis Today.
adult ITP
American Society of Hematology
ASH
Blood Disorders
Clinical Guidelines
Clinical Practice Guidelines
evidence-based medicine
first line therapy
Headlines
Hematology
Hematology Research
Hemostasis News
Hemostasis Today
Immune thrombocytopenia
ITP
ITP Treatment
Primary ITP
second line therapy
Shared Decision Making
thrombocytopenia
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC